AFM Image-Based Binding Assay CISMM: Computer Integrated Systems for Microscopy and Manipulation Collaborators: Jude Samulski (UNC Gene Therapy Center),

Slides:



Advertisements
Similar presentations
Numerical Modeling of Polyelectrolyte Adsorption and Layer-by-Layer Assembly Department of Chemical & Biological Engineering and School of Biomedical Engineering.
Advertisements

HIV and its lifecycle Sources: Wikipedia, HIV is a retrovirus (enveloped viruses possessing an RNA genome,
Utilizing Biochar for the Development of Carbon-based Biocatalyst
Chemical Genomics – Biol503 Lecture 4 Other Applications of Chemical Genomics.
Cystic Fibrosis: A Rheological Catastrophe CISMM: Center for Computer Integrated Systems for Microscopy and Manipulation Collaborators: Bill Davis 2, Ric.
Viruses and Gene Therapy
Investigating Ciliary Beat Patterns through Correlated AFM, Fluorescence and Electron Microscopy: Structure, Dynamics, Forces CISMM: Computer Integrated.
HIV and AIDS Human Immunodeficiency Virus (HIV) is the virus that causes Acquired Immunodeficiency Syndrome (AIDS).
High Efficiencies of Gene Transfer with Immobilized Recombinant Retrovirus: Kinetics and Optimization Claudel Olivier.
VIRUS ENTRY.
1 Antimicrobial Therapy Chemotherapy: any treatment of patient with chemicals to treat a condition. –Now word associated with cancer treatment –Our focus.
Vaccines and Antivirals. Clinical Use of Interferon Therefore they have been used in the treatment of cancers of various types. Therefore they have been.
Viruses.
Anti-idiotypes and Immunity Dr. Ziad Jaradat. Anti-idiotypes and Immunity The immune system of an individual can make millions of different kinds of antibodies:
Gene therapy progress and prospects cancer. Gene Therapy Primary challenge for gene therapy – Successfully delivery an efficacious dose of a therapeutic.
Nanoparticles and their medical applications
with an emphasis on DNA microarrays
Viruses are used for gene therapy
Nanobiotechnology and its Applications Chris Wright Nick D’Souza Kyle Ramirez.
Unit 3 Biology: signatures of life conceptual framework
Gene Therapy is the Path to a Cure Keith R. Jerome, MD, PhD Fred Hutchinson Cancer Research Center Seattle, Washington USA.
ENZYME ACTION!!!. What are Enzymes? An enzyme is a biological catalyst. It speeds up a chemical reaction without being used up in the reaction or becoming.
20/03/2008 Dept. of Pharmaceutics 1. Use of BIOINFORMATICS in Pharmaciutics 2  Presented By  Shafnan Nazar  Hamid Nasir 
Biological Nanomachines: Viruses. What are Viruses? Extremely efficient and well-designed to enter the body, travel through blood- stream, then attach,
Samudrala group - overall research areas CASP6 prediction for T Å C α RMSD for all 70 residues CASP6 prediction for T Å C α RMSD for all.
1 Biological Discovery High Volume Screening Combinatorial Diversity Structure, Design, Informatics Lead Series Biodisposition Toxicity Efficacy Pharmacokinetics.
Receptor/enzymes. Drug Design Most drugs work on proteins Somehow interfere with a biochemical process –Can shut down –Can activate.
Models for More Complex Enzyme Kinetics Allosteric enzymes - Some enzymes have more than one substrate binding site. - Allostery or cooperative binding:
Epigenetic Processes from a Molecular Perspective INBRE Meeting 2/16/10.
Overview of Bioinformatics Module Denis Manley.. Contact Details Lecturer Name: Denis Manley Room number: KE-1-013a
professor in microbiology
HIV Human Immunodeficiency Virus
Viral Replication Subtitle.
“Neutralizing Antibodies Derived from the B Cells of 1918 Influenza Pandemic Survivors” (Yu et. al) Daniel Greenberg.
Retroviral Gene Therapy. What is Gene Therapy? Gene Therapy Strategies.
NON-VIRAL GENE THERAPY Amanda Aryee. Gene Therapy Gene therapy is the process of introducing foreign DNA into host cells. Gene therapy has the potential.
Nanotechnology Tim Tice March 6, What is Nanotechnology? Two components of Nanotechnology Two components of Nanotechnology Processing and production.
Gene Therapy Mostafa A. Askar NCRRT By M.Sc. In Molecular Biology
Developing Confocal Raman-AFM and Fluorescence-AFM Imaging Techniques to Visualize Drug-Cell Interactions with Further Implications in Cellular Pathology.
Abira Khan.  Changes in host cell structure 1.Cell rounding, detachment from substrate 2.Cell lysis 3.Syncytium formation 4.Inclusion body formation.
Gene therapy and viral vector
Teaching Aids Service by KRRC Information Section.
Enzymes: the proteins in our body that get the chemical reactions necessary of life done common enzyme found in nearly all living organisms which are exposed.
KEY CONCEPT Entire genomes are sequenced, studied, and compared.
Nanomedicine Research at OU
THE INFECTIOUS PROCESS FOR A VIRUS Despite their simplicity relative to bacteria, viruses still possess various biochemical targets for potential attack.
University of Leicester
APPLICATIONS OF BIOINFORMATICS IN DRUG DISCOVERY
Gene Therapy and Viral Vector
Development and characterisation of laser-patterned polymer substrates for controlling cell growth Michael Irving.
Sdab library antibodies from camelized human antibodies. In particular, single domain antibodies combine the benefits of conventional antibodies with important.
Drug Affinity Responsive Target Stability (DARTS).
Molecular Docking Profacgen. The interactions between proteins and other molecules play important roles in various biological processes, including gene.
Human Health and Disease
Introduction Viral Structure
Mirjam B. Zeisel, Isabel Fofana, Samira Fafi-Kremer, Thomas F. Baumert 
Viruses.
Bioreactors Engineering
Volume 9, Issue 5, Pages (May 2002)
V. Protein Chips 1. What is Protein Chips 2. How to Make Protein Chips
Amino Acids An amino acid is any compound that contains an amino group (—NH2) and a carboxyl group (—COOH) in the same molecule.
Volume 14, Issue 1, Pages (July 2006)
Engineering Viral Genomes: Adeno-Associated Vectors
Lecture-16 Viruses.
KEY CONCEPT Entire genomes are sequenced, studied, and compared.
The Biological Catalysts
Volume 9, Issue 5, Pages (May 2002)
Volume 15, Issue 7, Pages (July 2007)
Thomas Gaj, Benjamin E Epstein, David V Schaffer  Molecular Therapy 
Hildegard Büning, Arun Srivastava 
Presentation transcript:

AFM Image-Based Binding Assay CISMM: Computer Integrated Systems for Microscopy and Manipulation Collaborators: Jude Samulski (UNC Gene Therapy Center), Doug McCarty (UNC Gene Therapy Center) Project Lead: Jian Liu (Schooll of Pharmacy) Investigators: Atsuko Negishi, Richard Superfine = de-OS heparin = de-6-OS heparin = de-NS heparin = de-2-OS heparin Silicon chip Fiducial marks Punch wells Biotinylate Si PDMS block Place PDMS on silicon chip Plasma treat PDMS wells on substrate Array Chip Mini-Well Array Assembly Project Motivations and Objectives: Viral Binding Studies for Gene Therapy Development: Mini-Well Array Methodology, Heparan Sulfate Surface Functionalization Viral infections rely on the virion particle binding to cell surface receptors. Understanding the mechanisms involved in this interaction is relevant in research fields such as gene therapy, drug development and delivery, and biosensors. In collaboration with UNC Gene Therapy Center and School of Pharmacy, we are specifically investigating the interaction between human parvovirus adeno-associated virus type 2 (AAV2), a potential viral vector, and heparan sulfate proteoglycan (HSPG), a cell surface receptor for AAV2. AAV is a highly attractive gene therapy vector due to its stability, low toxicity, low immunogenecity and ease in large scale production. AAV has been identified as a potential vector to treat numerous diseases such as brain tumors, muscular dystrophy, hemophilia and cystic fibrosis. A limitation of AAV is its broad host range which makes treatment of specific tissues difficult. Research efforts have been directed to target the vectors to specific cell types by modifiying the binding sites on the capsid. Experiments: Binding Specificity, Binding Isotherms, Inhibition Studies We have developed an assay system which utilizes photolithography, functionalized silicon surfaces, PDMS mini-wells and atomic force microscope (AFM) imaging to study the specific interactions between HS and AAV. Viruses were adsorbed on to HS functionalized surface and virus receptor binding is directly measured using the AFM. Another advantage of using the AFM is its ability to simultaneously provide structural and quantitative information about the binding interaction at the virus concentration (nM) virus density (particle/mm 2 ) The AFM-based methodology is currently used to study the binding interaction between adeno- associated virus type 2 (AAV2), a potential viral vector, and heparan sulfate (HS), an AAV2 cell surface receptor. Adsorption of AAV2 on to the functionalized surfaces are analyzed using the AFM. Binding of different AAV serotypes on the HS-modified surface confirmed that AAV2 and AAV3 have significant HS binding compared to AAV1 and AAV5. Isotherms are performed to determine binding constants of proteins. A binding constant of 340pM was determined for AAV2 to HS. IC 50 s of relevant molecules (such as chemically de-sulfated heparin) can be determined by performing inhibition studies in the reaction wells and using AFM to analyze the variance in the virus adsorption density. Preliminary results indicate a strong interaction between de-2-OS heparin and AAV2. Inhibition studies can lead to discovering potential anti-viral drugs as well provide structural information about the number of binding sites on the capsid. AFM Image of the mini-well edge after Neutravidin deposition. step height = 3.1 nm array chip Biotin-Si Neutravidin NH 2 OH UV Exposure 1 APTES vapor deposition 2 NHS-LC-LC-biotin 3 Neutravidin deposition 4 Biotinylated-HS deposition 5 Surface Modification Steps Binding Isotherm Inhibition Studies Further understanding of the interactions between AAV capsid proteins and heparan sulfate (HS) will aid in the modification of the AAV for tissue specific infectivity. Heparan sulfate is a polysaccharide chain of sulfated iduronic/glucuronic and sulfate glucosamine residues and can be differentiated into sequence specific structures by enzymes. These enzymatic modifications, known as heparan sulfate sulfotransferase modifications, have been shown to change the biological nature of heparan sulfate such as specific binding to proteins and viruses. For understanding HS-assisted viral infection mechanisms, we are interested in investigating the binding affinity and stability of AAV to different HS structures. We have developed a model heparan sulfate surface in which AAV adsorption studies are done and analyzed using the atomic force microscope (AFM). single molecule level in a controlled environment. In addition, the system has the flexibility to independently study different viruses binding to the same receptor, the same virus binding to different receptors, or use soluble molecules to compete with the virus-receptor binding. This technique has been optimized to minimize reagent use (reaction volumes can be as small as 1  l) and to facilitate analysis. Log (inhibitor concentration) (mM) virus density (particles/25 mm 2 ) Serotype <0.00 AAV ± ± 0.06AAV ± ± 0.06AAV ± ± 0.05AAV1 Neutravidin bHS Density of AAV on Substrate Surface Binding Specificity (# of particles/  m) Note: lines are only guides for the eye